QB3 to Collaborate with Johnson & Johnson Innovation on New Incubator
Agreement Expands Janssen Labs to New San Francisco Life Sciences Incubator
SAN FRANCISCO, June 5, 2013
SAN FRANCISCO, June 5, 2013 /PRNewswire-USNewswire/ -- The California
Institute for Quantitative Biosciences (QB3) has signed an agreement with
Johnson & Johnson Innovation to allocate 5,000 square feet of the space in
QB3's new 24,000-square foot biosciences incubator in San Francisco to launch
Janssen Labs @QB3.
Under the collaboration, Johnson & Johnson will have an exclusive agreement to
create a Janssen Labs facility within the new incubator at 953 Indiana St.,
near the UC San Francisco (UCSF) campus at Mission Bay, with an option to
The new space, known as QB3@953, is the fifth and largest incubator launched
by the state institute and central to QB3's mission to help build the state's
bioeconomy by giving startups the tools they need to succeed. By working with
Johnson & Johnson's new California Innovation Center in Menlo Park and with
Janssen Labs, QB3 hopes to connect startups to partners that can boost their
"Connecting biotech startups to experts in multiple areas of the bioscience
industry is critical in helping entrepreneurs launch viable companies," said
QB3 Associate Director Douglas Crawford. "This collaboration can help expand
QB3's network of entrepreneurs, while also bridging the gap for many
technologies that would not otherwise have a chance to develop."
The agreement marks the first geographical expansion of Janssen Labs, a San
Diego life-science incubator that is currently home to 29 companies. Janssen
Labs @QB3 will have a similar open-innovation approach to the San Diego labs,
in which entrepreneurs have the benefit of the insights of a major healthcare
company, with no strings attached. Johnson & Johnson affiliates will identify
innovators who are developing promising science to address important unmet
Companies in Janssen Labs @QB3 will have access to QB3's resources, which
include legal and business advisors, assistance in grant writing for federal
Small Business Innovation Research funds, and access to high-end equipment and
technology in UCSF facilities.
"The partnership is about lifting up courageous scientists who are out there
on the edge of discovery, without compromising their intellectual property,"
Crawford said. "Our hope is that this support will greatly increase the
chances of these companies having an impact on both our economy and our
The QB3 system also includes two facilities on and adjacent to the UCSF
Mission Bay campus, and two others in Berkeley. QB3 is leasing the new space
through Dewey Land Co. and will sublease it directly to entrepreneurs.
Ultimately, the new incubator aims to house 20 to 30 new startup companies.
Those startups will lease space as at the other QB3 incubators: in amounts as
small as a single research bench, making state-of-the-art laboratory space
affordable to fledgling operations. QB3@953 will be open to life science
startups from both within the University of California and from the outside.
QB3 is a cooperative effort among private industry and more than 220
scientists at UC San Francisco, UC Berkeley and UC Santa Cruz. One of four
technology institutes created in 2000 by former California Governor Gray
Davis, QB3 has a joint mission of supporting science, driving the California
economy and transforming scientific research into public good.
Fundamental to the latter two missions are QB3's efforts to commercialize
University of California science by creating mutually beneficial partnerships
with industry and supporting innovative entrepreneurs. The effort has led to
54 bioscience startup companies currently in QB3's incubator network. QB3 also
operates Mission Bay Capital, an $11.3M seed-stage venture capital fund
designed to support UC startups. For more information on QB3, visit
SOURCE California Institute for Quantitative Biosciences (QB3)
Press spacebar to pause and continue. Press esc to stop.